Evgeny Zaytsev

About

Dr. Evgeny Zaytsev is a successful venture capitalist with twenty years of investment experience in life sciences. He is a Co-founder and general partner at Helix Ventures (Palo Alto, California), a venture firm investing exclusively in novel therapeutic opportunities (biopharmaceuticals and medical devices), and formerly a managing partner at RMI Partners (Palo Alto, California). Prior to Helix, he was a partner of the venture capital pioneer Pitch Johnson at Asset Management Company, one of the oldest venture firms in Silicon Valley. Dr. Zaytsev is involved in more than 30 investments, including such success stories of venture capital as Transcend Medical (acquired by Alcon), Clearside Biomedical (IPO NASDAQ: CLSD), Coherus Biosciences (IPO NASDAQ: CHRS), BiPar Sciences (acquired by Sanofi-aventis), Chimerix (IPO NASDAQ: CMRX), Fusion Medical Technologies (acquired by Baxter), MicroVention (acquired by Terumo Corp), TriVascular (acquired by Boston Scientific). He has been a Boar

Investment Focus

Location

Palo Alto, US